Comparison of Biphasic Insulin Aspart 30 Twice Daily With Two Different Initial Dosage Split Regimens in Subjects With Type 2 Diabetes: An Extension to Trial BIASP-3756
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 179 participants.
Also called NCT01278160
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 179 participants
- Sponsor
- Registry
-
NCT01278160
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01278160. Randomized; no masking; primary purpose treatment. Start 2011-01 (registry gives no type); primary completion 2011-09 (actual). Results posted on 2012-10-18.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Biphasic Insulin Aspart 30 Twice Daily With Two Different Initial Dosage Split Regimens in Subjects With Type 2 Diabetes: An Extension to Trial BIASP-3756
- Condition
- Diabetes
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- biphasic insulin aspart 30
- Intervention (Drug)
- biphasic insulin aspart 30
- Intervention (Drug)
- metformin
- Lead sponsor
- Novo Nordisk A/S
Record details
- Record id
cardio:ct-nct01278160- Content hash
e67d0338432a345a7fea998f91b539772045c60c4aba892746b6d1c95c5bd517